Cipla Ltd

CIPLA · NSEHealthcareNSE session: Live

₹1,467.90

+₹4.1 (+0.28%) today

Delayed market data

Practice terminal

Price

Delayed market data

loading…

Key metrics

Via screener.in

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/CIPLA/). Figures are as published there; anything not published is shown as unavailable.

Market cap

₹1.18L Cr

P/E ratio

36.10

P/B ratio

—

Dividend yield

0.89%

52W high

₹1,673.00

52W low

₹1,166.00

Volume

5,62,150

Beta

—

Factual checks

Via screener.in

Statements of what the filings say. There is no score, grade or pass/fail here — reading these numbers is your call.

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/CIPLA/). Figures are as published there; anything not published is shown as unavailable.

Return on capital employed

13.7% as published by screener.in for the period ended 30 June 2026.

Return on equity

10.4% as published by screener.in for the period ended 30 June 2026.

Dividend yield

0.89% as published by screener.in for the period ended 30 June 2026.

Price to earnings

36.1× as published by screener.in for the period ended 30 June 2026.

Book value per share

₹423 as published by screener.in for the period ended 30 June 2026.

Face value

₹2 as published by screener.in for the period ended 30 June 2026.

Return on equity

10.40%

Debt to equity

—

About the company

Via screener.in

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/CIPLA/). Figures are as published there; anything not published is shown as unavailable.

Incorporated in 1935, Cipla Ltd is in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and APIs [1]

Founded

Headquarters

IndustryPharmaceuticals

Educational only · not investment advice. Virtual money · educational only · not investment advice. Market data is delayed and indicative. Investments in securities markets are subject to market risks. Operating entity and registration details: see Terms & Disclaimer.